Home > Insider Trading > Filing (0000885590-15-000047)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885590	Valeant Pharmaceuticals International Inc.	VRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1577638	Pavel Mirovsky	2150 St. Elzear Blvd. West Laval A8 H7L 4A8	Evp, Pres. & Gm Valeant Emena	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, No Par Value	Acquisiton	2015-06-01	100	$51.01	36,775	No	4	M	Direct
Common Stock, No Par Value	Disposition	2015-06-01	100	$240.00	36,675	No	4	S	Direct
Common Stock, No Par Value	Acquisiton	2015-06-02	14,900	$51.01	51,575	No	4	M	Direct
Common Stock, No Par Value	Disposition	2015-06-02	14,900	$237.94	36,675	No	4	S	Direct
Common Stock, No Par Value	Disposition	2015-06-02	23,000	$238.04	13,675	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares, No Par Value	Non-Qualified Stock Options (right to purchase)	Disposition	2015-06-01	100	$0.00	100	$51.01
Common Shares, No Par Value	Non-Qualified Stock Options (right to purchase)	Disposition	2015-06-02	14,900	$0.00	14,900	$51.01

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
19,900	2016-05-15	2022-05-15	No	4	M	Direct
5,000	2016-05-15	2022-05-15	No	4	M	Direct

Footnotes

This number represents the weighted average sale price for all sales of common stock acquired upon exercise of options and sold. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price.
This number represents the weighted average sale price for all sales of common stock previously held that were sold. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price.
The options vested one-fourth per year over four years starting with the first vest date falling on the first anniversary of the equity grant date, the second vest date falling on the second anniversary of the equity grant date, the third vest date falling on the third anniversary of the equity grant date, and the fourth vest date falling on the fourth anniversary of the equity grant date.